Lipocine Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Salt Lake City, United States
SEC filing record 1 source field available
Fiscal year end
31 December
Lipocine Inc. has filed 806 SEC EDGAR filings since 30 Nov 2011

SEC filing history

Showing 151-175 of 806 matching filings.

Per page
25
Current page
7
4

4 filing

Filing date
25 May 2023
Reporting date
25 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 May 2023
Reporting date
10 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 May 2023
Reporting date
10 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 May 2023
Reporting date
10 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 May 2023
Reporting date
10 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 May 2023
Reporting date
10 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-36357

10-Q filing

Filing date
11 May 2023
Reporting date
31 Mar 2023
Next action
Verify source filing
424B5 File 333-250072

424B5 filing

Filing date
03 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36357

DEF 14A filing

Filing date
27 Mar 2023
Reporting date
27 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
24 Mar 2023
Reporting date
24 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
20 Mar 2023
Reporting date
20 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-36357

ARS filing

Filing date
20 Mar 2023
Reporting date
31 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Mar 2023
Reporting date
17 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .